EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Prescribing Patterns of Antidiabetic Agents and Glycemic Control in Type 2 Diabetes Mellitus Patients

Deepti Shrestha, Radhay Shyam Yadav, Rekha Paudel, Rashmi Shakya Gurung

Journal of Institute of Medicine Nepal · 2026-04-30 · 48 (1) · 156-162

DOI: 10.59779/jiomnepal.1441 ↗
AbstractBibliografische Angaben

Abstract

Introduction Despite the availability of several effective classes of antidiabetic drugs, many Type 2 diabetes mellitus (T2DM) patients continue to have inadequate glycemic control. This study aimed to assess the prescribing patterns of antidiabetic agents and evaluate glycemic control in T2DM patients. Methods A descriptive cross-sectional study was conducted in Medicine outpatient department of tertiary care hospital. Patient demographic profile, antidiabetic medicine, number of antidiabetic medicine, blood HbA1c were recorded in a pre-designed proforma. The collected data was analyzed with SPSS software version 16.00. Result Out of 148 patients, female patients constituted a higher proportion of the study population (83, 56.1%) and common age group ranging from 51-60 years (45, 30.4%). Biguanides were the most frequently prescribed antidiabetic agents (134, 90.5%). Dual therapy was the most commonly prescribed regimen (54, 36.5%), where the combination of metformin and sulfonylureas was the most frequently used regimen (22, 14.9%). HbA1c levels showed that only 66 (44.6%) of patients had good glycemic control. Conclusion Metformin-based therapy remained the cornerstone of T2DM management; however, a considerable proportion of patients fail to achieve optimal glycemic control.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →